Acute and Sub-Acute Toxicity of Aqueous Extract of Nauclea Latifolia in Swiss Mice and in OFA Rats by Kouadio, JH et al.
Kouadio et al 
Trop J Pharm Res, January 2014; 13(1): 109  
 
Tropical Journal of Pharmaceutical Research January 2014; 13 (1): 109-115 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v13i1.16 
Original Research Article 
 
 
Acute and Sub-Acute Toxicity of Aqueous Extract of 
Nauclea Latifolia in Swiss Mice and in OFA Rats  
 
James H Kouadio*1, Mathieu N Bleyere2, Mama Kone2 and Sébastien D Dano3 
1Department of Biochemistry and Microbiology, UFR Agroferesterie, Daloa University, BP 150 Côte d’Ivoire  
2Laboratory of Physiology, Pharmacology and Phytotherapy, UFR des Sciences de la nature, Nangui Abrogoua University, 02 
BP 801 Abidjan 02, Côte d’Ivoire. 
3UFR des Sciences Pharmaceutiques et Biologiques, University of Félix Houphouet BOIGNY 21 BP 632 Abidjan 21, Côte 
d’Ivoire 
  
*For correspondence: Email: jameshalbink@yahoo.fr  Tel: 09 54 41 60 
 
Received: 06 July 2012        Revised accepted: 16 December 2013 
 
Abstract 
Purpose: To determine the dose – toxicity profile of the aqueous extract of Nauclea latifolia stem bark 
(AQE).  
Methods: Oncin France Souche A (OFA) rats were orally administered with AQE at doses of 1.8, 18 
and 180 mg/kg body weight for 28 days. In parallel, oral acute toxicity test in Swiss mice was performed 
with AQE at doses of 2, 4, 8 and 18g/kg body weight. Blood, urine and other biochemical markers were 
assessed for the rats. 
Results: No death was observed after 14 days of single oral administration, and hence the LD50 was > 
18g/kg body weight. For sub-acute toxicity in OFA rats, an elevation of some blood parameters 
(platelets and erythrocytes but also eosinophils) in contrast to the low serum concentrations of 
biochemical markers such as aminotransferases (ALT, AST) and creatinine were recorded in rats 
treated with 18 and 180 mg/kg body weight. Urine analysis showed high depletion of sodium and 
potassium ions coupled with high loss of water.  
Conclusion: Known for its diuretic property, the AQE could be beneficial against anemia and may favor 
blood coagulation but unfortunately may exhibit allergenic properties and cause inflammatory reactions. 
This study suggests the no-observed-adverse-effect-level (NOAEL) of AQE range between 1.8 and 18 
mg/kg body weight in OFA rats. 
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Nauclea latifolia (Rubiaceae) commonly known 
as pin cushion tree is a straggling shrub or small 
tree native to tropical Africa and Asia and it 
grows up to an altitude of 200 m. Infusions and 
decoctions of parts of Nauclea latifolia are 
commonly prescribed traditionally as a remedy 
for diabetes mellitus and it has been reported 
that the aqueous extract of Nauclea lalitifolia had 
been found to exert hypoglycaemic activity in 
alloxan-induced diabetic rats [1]. The plant is 
also used as a chewing stick [2] and in the 
treatment of ailments like gastrointestinal tract 
disorders, tuberculosis, sleeping sickness, 
prolongs menstrual flow, hypertension and 
malaria [3-9]. More recently, it had been reported 
the presence of biologically active principles in 
the extract with anti-nociceptive, anti-
inflammatory and anti-pyretic activities that 
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justifies its use in malaria ethnopharmacy and 
subsequent development for clinical application 
[1].  Indeed, all plant parts of the Nauclea 
species are a rich source of monoterpene indol 
alkaloids namely indole alkaloid strictosamine 
[10-12] but also terpenes [13] saponines and 
active polyphenols [2]. Moreover, the ethanolic 
extract of Nauclea latifolia had been found to 
posses anti-hepatotoxic and trypanocidal 
activities [3]. Despite the numerous studies on 
pharmacology activities of aqueous or ethanolic 
extract or biologically active principles of N. 
latifolia, very few studies were reported on its 
systemic toxicity. The few data on the plant 
toxicity revealed that the LD50 was higher than 
1600 mg/kg/bw after intraperitoneal (IP) injection 
of mice [14] and alkaloid rich extracts from the 
Nauclea latifolia can interact in vitro with DNA of 
bacteria and mammalian cells, leading to G2-M 
cell cycle arrest and heritable DNA-damage and 
cause single-strand breaks in liver, kidney and 
blood cells [15]. But, more recently, it has been 
reported that repeated administration for 28 days 
of high doses (200, 400, 600 and 800 mg/kg 
body weight) of aqueous extract of Nauclea 
latifolia evident stem may lead to damage in the 
kidney and liver [16].  
 
In Côte d’Ivoire, the aqueous extract of stem bark 
of N. latifolia (AQE) is largely and daily used 
against malaria and its symptoms such as fever. 
In these circumstances, the toxicity of plant after 
oral repeated administration must be clarified. 
The available low dose toxicity profile of AQE is 
extremely limited. Short-term exposure to high 
doses of aqueous extract of plant induces 
various metabolic changes and toxic responses, 
however, extrapolation of these findings to the 
long-term and low-dose exposures to human are 
subject is highly problematic [16]. Since, 
additional experiments to investigate NOAEL are 
indispensables, OFA rats were orally 
administrated with 1.8, 18 and 180 mg/kg of AQE 
for 28 days. In parallel, we performed oral acute 






For acute toxicity, the animals used were male 
Swiss albino mice from the Pasteur Institute of 
Adiopodoumé (Abidjan) and aged 5 to 8 weeks 
with weight between 20 and 25 g. The animals 
were acclimatized to the laboratory for 1 week 
prior to the test.  
 
For sub-acute toxicity, male and female OFA rats 
(5 – 8 week old), weighing between 100 and 120 
g were obtained from the Pasteur Institute of 
Abidjan. The rats were housed in 
environmentally protected transparent polypropy-
lene cages with stainless steel wire tops for a 
period of 1 week before commencement of the 
tests. The rats had free access to water. 
Experimental diets were placed in special 
containers to minimize spillage. Environmental 
conditions included 23 – 25 °C, relative humidity 




The plant material consists of stem bark of the 
plant which was dried and ground into powder 
before diluting in water. The aqueous extract 
(AQE) was obtained by maceration for 24h as 
traditional used in Côte d’Ivoire. The extract was 
filtered and lyophilized and the dried residue was 
diluted appropriately with water for oral 
administration to the experimental animals. 
 
Acute toxicity test 
 
The acute toxicity study was performed 
according to OECD 401 Guidelines for testing of 
chemicals [17]. The animals were placed in 
special cages for 7 days for acclimatization 
before the experiment. At the end of the seventh 
day, the animals were subjected to fasting for 24 
hours before oral administration of different 
doses of AQE. The mice were randomly divided 
into 5 groups of 3 female mice. Group I: normal 
control group, and the mice received water; 
Group II: 2 g/kg body weight AQE; Group III: 4 
g/kg body weight AQE; Group IV: 8 g/kg body 
weight AQE; and Group V: 18 g/kg body weight 
AQE. After administration of the extract, the 
animals were observed every 30 min for 8 h on 
the first day and once daily for 14 days. During 
this period, the liveliness, sensibility to painful 
stimulation, visual acuity and texture of the 
faeces were assessed. The LD50 of AQE was 
investigated based on the eventual observed 
mortality.  
 
Sub-acute toxicity test 
 
The protocol of sub-acute toxicity study 
performed according to from OECD 407 
Guidelines for testing of chemicals [18]. The 
protocol was approved by the committee of 
Bioethics of Nangui Abrogoua University, Abidjan 
(Côte d’Ivoire). Total of 40 rats (20 males and 20 
females) was randomly divided into 4 groups (n = 
10 per group with 5 females + 5 males) and 
housed under standard husbandry condition for 
one week before the experiment and allowed 
with standard feed in solid (balls). The animals 
were divided into the following 4 groups: Group 
A: normal control group and mice received water; 
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Group.B: 1.8 mg/kg body weight AQE; Group C: 
18 mg/kg body weight AQE; and Group D: 180 
mg/kg body weight AQE. Each group received 
the appropriate vehicle (water) and AQE daily by 
oral administration for 28 days. All the rats were 
weighed on a Sartorius balance (ED 224S, 
Germany), with 0.0001 mg accuracy, prior to 
treatment. Urine and blood were collected from 
the rats at the end of each week for urine and 
hematological analysis. After 28 days, blood and 
urine were again collected, all the animals 





Urine samples collected by refrigerating 
metabolic cages (Tecniplast, Bugugiate, Italy) 
were analyzed for pH, albumin, glucose, ketone 
body using dipsticks (Ames Labstix Bayer 
Dignostic). In addition, the urinary sodium and 
potassium ions were analyzed using a PFP7 
flame photometer (Jenway).  
 
Evaluation of hematological parameters 
  
The analysis of blood samples was performed 
using an analyzer, Beckman Coulter T540. The 
hematological parameters including the number 
of leukocytes, erythrocytes, hemoglobin (Hb) 
concentration and the platelet count were 
determined. White blood cells or leukocytes were 
analyzed using pap test with May-Grünwald 
Giemsa (MGG) blood staining for the 
determination of percentage (%) of leukocytes 
including lymphocytes, monocytes and 
phagocytes, and granulocytes (neutrophils, 
eosinophils and basophils). 
 
Assessment of biochemical parameters  
 
The serum biochemistry parameters including 
aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), creatinine and urea 
were evaluated spectrophotometrically using an 
automated HumaStar 80 (Human GmbH, 
Germany). 
Statistical analysis  
 
The data generated were statistically processed 
using SPSS 11.19 statistical software. Analysis 
of variance (ANOVA), with Tukey post-hoc test to 
identify the variable(s) with very significant 
differences vis-a-vis the control group, was used 
to analyse the data from the evaluation of 
hematological and biochemical parameters. At 
95% confidence interval, p values < 0.05 were 






Following the administration of single dose of 2, 
4, 8 and 18g/kg body weight of AQE to mice, no 





General observation and body weight 
 
At the end of the 4th week of the experiment (day 
28), no variation of the vivacity, sensitivity to 
noise and to painful stimulation was noted in both 
experimental and control groups. In addition, the 
macroscopic observation of each animal’s 
tissues was not revealed any changes but, the 
water was rich in the faeces of experimental 
animals and as compared to control, animals 
treated with AQE at doses 1.8 and 18mg/kg 
increased in body weights, in contrast to those 




The results of hematology and serum 
biochemical examinations are summarized in 
Tables 2 - 5. Serum creatinine, AST and ALT 




Table 1: Weight of female and male rats after treatment with AQE at various doses for 4 weeks 
                 
Dose (mg/kg)  Day 0 Day 7 Day 14 Day 21 Day 28 
Males      
Control 82±2.7 88±2.5 95.5±2 97.5±3 105±2.5 
1.8 79±2.8 85±2.3 90.5±3 103±2.8 113±3* 
18 78±2.5 88±3 91±3.2 94±3.6 100±3.2 
180 80±3 87±2.4 99±2.2 101±3 93±3.2* 
Females 
Control 80±2.3 86±3 90±2.9 91±2.9 102.5±3 
1.8 78±2.4 84±2.6 96±3 105±3 115±2.7* 
18  77±3 87±4 88±3.5 89±3.2 91±3* 
180  81±2.8 88±3 89±2.7 91±3.2 86±3* 
    *Significantly different from control group ( p <0.05) 
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Table 2: Serum chemistry of OFA rats administered with AQE at doses of 1.8, 18 and 180 
mg/kg on Day 28 
 
Dose (mg/kg) AST (IU/l) ALT (IU/l) Urea (g/l) Créatinine (mg/dl) 
Male     
Control 198.7±21 64.55±6 0.89±0.12 30.3±2 
1.8  169.8±24 55.7±4.5 0.73±0.1 28.3±1.8 
18 *115.2±15 *40.4±3.3 0.69±0.09 *20.5±2.2 
180 *82.3±17 *32.2±7.1 0.89±0.15 *17.5±1.2 
Female     
Control 163.5±10.6 65.6±8 0.62±0.08 35±3.8 
1.8 161.5±14 51.5±6.3 0.65±0.06 28.33±3.2 
18 *92.6±12 *40.9±3.2 0.69±0.04 *18.4±2.5 
180 *62.6±9.8 *28.6±2.7 0.70±0.07 *16.4±1.5 
*Significantly different from control group at p <0.05 
 




Day 7 Day 14 
AQE dose (mg/kg/bw) AQE dose (mg/kg/bw) 
0 1.8 18 180 0 1.8 18 180 
Leukocytes 5.1±0.9 4.8±1.2 4.6±1 4.6±0.7 4.6±1.1 4.7±1.4 4.7±0.5 4.7±0.9 
Neutrophils (%) 20 22 21 21 24 21 21 27 
(109/l) 0.8 0.88 0.84 0.84 0.94 0.84 0.84 1.08 
Eosinophils (%) 0 0 0 *2 0 0 0 *2 
(109/l) 0 0 0 *0.08 0 0 0 *0.08 
Basophils (%) 0 0 0 0 0 0 0 0 
Monocytes (%) 0 0 0 0 0 0 0 0 
Lymphocytes (%) 86 79 76 *74 74 78 78 71 
(109/l) 4.3 4 3.8 3.7 3.7 3.9 3.9 3.6 
Erythrocytes 3.1±0.3 3.6±0.4 2.9±0.2 3.1±0.4 3.7±0.2 3.7±0.3 4.1±0.5 4.2±0.4 
Hemoglobin 6.4±0.4 8.2±0.9 5.7±0.4 5.5±0.6 7.3±0.5 7.3±0.3 8.1±0.6 5.5±0.4 
Platelets 366±12 480±16 420±21 391±19 434±11 392±16 424±14 434±10 
 
Males (2) 
Day 21 Day 28 
AQE dose (mg/kg/bw) AQE dose (mg/kg/bw) 
0 1.8 18 180 0 1.8 18 180 
Leukocytes 4.8±1.1 4.9±1 4.9±0.9 4.9±1.3 4.8±0.9 4.8±0.7 4.7±1.2 4.7±0.9 
Neutrophils    (%) 23 25 *13 *16 14 16 *24 21 
(109/l) 0.92 1 *0.52 *0.64 0.56 0.6 *0.94 0.84 
Eosinophils    (%) 1 1 0 2 0 0 0 *2 
(109/l) 0.04 0.04 0 0.08 0 0 0 *0.08 
Basophils (%) 0 0 0 0 0 0 0 0 
Monocytes (%) 0 0 0 0 0 0 0 0 
Lymphocytes (%) 
(109/l) 
76 77 *87 *84 85 84 *76 *76 
3.8 3.9 4.4 4.2 4.3 4.2 3.8 3.8 
Erythrocytes 4.3±0.5 4.5±0.4 4.7±0.6 4±0.3 4.8±0.2 4.7±0.4 4.8±0.3 *5.7±0.3 
Hemoglobin 8.4±0.6 8.3±0.3 9.5±0.9 7.9±0.4 9.3±0.8 8.3±0.5 10.5±1 *11.5±1 
Platelets 511±20 528±19 *764±9 *723±8 502±19 479±11 *574±9 *577±12 
Bw = body weight; Leukocytes (103/mm3); erythrocytes (106/mm3); hemoglobin (g/dl); platelets (103/mm3); 
*significantly different from control group at p <0.05 
 
18 and 180 mg/kg but the change was more 
pronounced at the latter dose. Erythrocytes, 
hemoglobin and platelets decreased at day 14 
only in female rats treated at a dose of 18 mg/kg 
of AQE. On day 21, however, platelets increased 
in male rats at doses i.e. 18 and 180mg/kg body 
weight. Moreover, the rates of erythrocytes and 
hemoglobin were elevated at day 28 only for 
males at dose of 180mg/kg body weight. The 
number of lymphocytes increased at 21 day but 
decreased at days 7 and 28 in treated groups (18 
and 180mg/kg body weight). Eosinophils were 
elevated in animals treated at a dose of 180 
mg/kg over the period of the test. The number of 
neutrophils decreased on day 21 for animals that 
received high doses of AQE but increased at day 
28 only with the highest dose in male rats, i.e., 
Group V (Tables 2 - 4). 
 
The results of urinalysis showed no significant 
ketone, glucose and albumin in the urine of all 
the treated animals throughout the duration of 
the experiment. Urinary pH ranged from 8.5 to 9 
while potassium and sodium ions (Tables 5 and 
6) showed significant variation from control. High 
depletion of sodium ion was observed in all  
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Day 7 Day 14 
AQE dose (mg/kg) AQE dose (mg/kg) 
0 1.8 18 180 0 1.8 18 180 
Leukocytes 4.4±0.6 4.8±0.5 4.2±0.3 *5±0.3 4.7±0.5 4.9±0.3 4.8±0.4 4.7±0.6 
Neutrophils    (%) 22 21 23 23 27 22 25 24 
                  (109/l) 0.88 0.84 0.92 0.92 1.08 0.88 1 0.94 
Eosinophils    (%) 0 0 0 *5 0 0 0 *5 
                  (109/l) 0 0 0 *0.2 0 0 0 *0.2 
Basophils (%) 0 0 0 0 0 0 0 0 
Monocytes (%) 0 0 0 0 0 0 0 0 
Lymphocytes (%) 70 78 65 80 73 80 75 71 
                  (109/l) 3.5 3.9 3.3 4 3.7 4 3.8 3.6 
Erythrocytes  3±0.1 3.2±0.1 3±0.2 3.1±0.1 4.2±0.3 4.1±0.1 *2.8±0.2 3±0.1 
Hemoglobin  5.4±0.3 6.6±0.2 5.3±0.1 5.5±0.1 7.9±0.4 8.2±0.5 *5.5±0.3 6.3±0.1 
Platelets  424±19 471±16 452±15 456±12 449±20 378±16 *241±18 440±13 
 
Females (2) 
Day 21 Day 28 
AQE dose (mg/kg) AQE dose (mg/kg) 
0 1.8 18 180 0 1.8 18 180 
Leukocytes 4.7±0.8 4.8±0.5 5.1±0.9 4.9±0.8 4.8±0.6 4.8±0.9 4.7±0.7 4.7±0.6 
Neutrophils    (%) 
                  (109/l) 
26 20 *14 20 23 19 20 23 
1.04 0.8 *0.78 0.8 0.92 0.76 0.8 0.92 
Eosinophils    (%) 
                  (109/l) 
1 2 0 *4 0 0 1 *7 
0.04 0.08 0 *0.16 0 0 0.04 *0.28 
Basophils (%) 0 0 0 0 0 0 0 0 
Monocytes (%) 0 0 0 0 0 0 0 0 
Lymphocytes (%) 
                  (109/l) 
72 78 *86 78 77 81 78 70 
3.6 3.9 *4.3 3.9 3.9 4.1 3.9 3.5 
Erythrocytes  5±0.2 3.8±0.2 4.2±0.5 4.6±0.3 5.6±0.3 5.6±0.2 5.4±0.2 5.5±0.4 
Hemoglobin  9.3±0.5 7.1±0.3 7.7±0.3 9.1±0.5 12.1±1 11.9±0.8 11.3±1 11±0.9 
Platelets  502±17 449±12 549±15 *739±9 573±13 607±17 590±18 554±16 
Leukocytes (103/mm3); erythrocytes (106/mm3); hemoglobin (g/dl); platelets (103/mm3);                 *significantly 
different from control group at p <0.05 
 
Table 5: Urinary concentrations of sodium ((Na+) and potassium (K+) ions for OFA male rats administered with 
AQE  
 



















Control 68.7±4 113.6±8 58.3±3.7 119±14 72.1±10 167.5±24 56±7 158±16 
1.8  66±5 116.5±7.3 64.7±5 141.7±16 62.17±7.5 139.8±21 51±6.5 147±20 
18  66.8±4.6 103.1±7 76.2±4.3 146.8±14 60.74±6.2 147±42 63.7±9 132.2±19 
180  *50.2±3.4 *74.2±6 *82.7±4.7 *90±4.3 *34.3±5.6 *59.3±9.7 *91.8±8.6 143.4±22 
*Significantly different from control group at p <0.05 
 






Day 7 Day 14 Day 21 Day 28 
Na+ 
(mEq/l) 












Control 40.9±7.9 144.2±21 80.7±9 128±9.2 108±18 131.2±8.2 53.7±4 126.7±9.2 
1.8  *81.1±9.6 131±23 72.6±6.5 120.9±7.5 104±13 135.7±14 47±4 129±10 
18  *80.4±12 125.7±17 71.4±8 135.1±9 94±17 150.3±22 79.3±4 119.96±9 
180  *107.7±13 *211.2±29 *58.6±4.5 *101±5.5 *34.6±11 *89.5±7.6 *91.8±4 144.3±12 
*Significantly different from control group at p <0.05 
 
female rats treated by AQE at day 7 and this high 
depletion was also observed on day 28 only in 
the female rats that received 180 mg/kg but 
decreased on days 14 and 21, compared to 
control. At the same dose, in male rats, sodium 
ion levels were elevated on days 14 and 28 but 
diminished on days 7 and 21. For potassium ion, 
at dose of 180mg/kg body weight, the values of 
unary concentration decreased only on days 7, 
14 and 21 in males and on days 14 and 21 in 
female rats, but showed an elevation on day 7. 
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The maximum acute dose of AQE administered 
(18 g/kg) is 7 times greater than 2.5 g/kg 
recommended for screening of plant toxicity [19]. 
For comparison, it was found that the LD50 of 
mebendazole was 640 mg/kg body weight in 
mouse [20]. The results of this study are 
supported by previous findings obtained from 
intraperitoneal and oral administration to mouse 
of both aqueous and ethanol extracts of the root 
and stem bark with the highest dose of the plant 
at 16 g/kg [14,21]. Therefore, the results of acute 
toxicity in the present study confirm the low 
toxicity of a single consumption of the stem bark 
extract of Nauclea latifolia as previously reported 
[14,21]. 
 
Although acute toxicity helps to determine 
substances that are non-toxic, it is important to 
assess sub-acute toxicity profile because it helps 
to evaluate morphological and physiological 
changes in organs. Toxicological evaluation by 
repeated doses have been generally accepted as 
a fundamental test for safety assessment. 
Although there are previous reports on the 
toxicological profile of AQE [16], however, 
available toxicological profiles of low doses of the 
plant including hematological parameters and 
NOAEL are limited. Furthermore, there is 
controversy over the sub-acute toxicity of AQE in 
rats [16,22]. It has previously been reported that 
the aqueous extract of N. latifolia did not 
significantly affect the liver, kidney, heart and 
hematological system of rats but could cause 
reduction in feeding and water consumption as 
well as body weight at the highest dose tested 
[22]. However, more recently, evident liver and 
kidney toxicities have been revealed [16]. 
 
In the present study, the mean gain in weight 
was high in groups which received AQE which 
may be due to the beneficial effect of the extract. 
After the consumption of AQE, animals showed a 
slight stimulation of appetite for food and water. It 
is known that in addition to their therapeutic 
properties, medicinal plants can affect positively 
the nutritional status of an animal [23]. However, 
the highest dose of AQE causedserious weight 
loss in the rats which could be explained by the 
high urinary excretion of water to the diuretic 
properties of N. latifolia . 
 
With the exception of serum urea, all serum 
parameters analyzed, namely, creatinine, ALT 
and AST decreased in a time- and concentration-
dependent manner. Since, these serum 
parameters were analyzed only at the end of the 
experiment, i.e., day 28, the high excretion of 
these parameters coincided with the very high 
urinary excretion of blood sodium and potassium 
ions. The kidney plays a very important role in 
the removal of metabolic wastes from the blood 
stream. Its functionality, therefore, can be 
assessed among many others by determining the 
serum concentration of excretory constituents 
[24]. The significant decrease in serum 
creatinine, sodium ion and potassium ion was 
probably linked to metabolic alkalosis as 
revealed by the values of urine pH of 8 - 9 for the 
4 weeks of study.  
 
AST and ALT levels in the groups which received 
high doses of the plant extract (18 and 180 
mg/kg) for 28 days may be suggestive of an 
alteration in the secretory and excretory functions 
of the kidney [24,25] caused by the extract of N. 
latifolia stem. Our findings are partially supported 
by a previous report [16] which found a decrease 
in serum creatinine and urea but increase in 
serum AST and ALT in rats treated with the 
aqueous extract of N. latifolia. The authors 
concluded that the extract of the plant may not 
only adversely interfere with amino acid 
metabolism of the liver but also cause a 
destruction of liver tissue in a time- and 
concentration-dependent manner [16]. That 
could explain the elevation of serum ALT and 
AST in contrast to the decrease in these serum 
parameters in the present study. The doses of 
AQE used in the present study (1.8, 18 and 180 
mg/kg) when compared to those previously used 
(200, 400, 600 and 800 mg/kg) [16] are not high 
enough to cause damage to liver tissue based on 
serum AST and ALT elevation.  
 
The effect of AQE on erythrocytes, hemoglobin 
and platelets was slightly beneficial at 18 and 
180 mg/kg doses on days 21 and 28. AQE 
probably exerts activity against anemia and may 
also enhance the blood coagulation. The effect of 
AQE on lymphocytes count was beneficial on 
day 21 of the experiment but on day 28, caused 
a reduction in lymphocytes indicating possible 
lymphocyte cell death. Moreover, AQE induced 
eosinophilia which occurs in some allergic 
diseases and infestations by large parasites. 
More likely, however, AQE may contain 
biologically active principles with allergenic 
properties. AQE modulated (diminished and 
increased) time-dependently neutrophil count; 
elevation of neutrophils could indicate 
inflammatory diseases induced by AQE or could 




Oral exposure of acute doses of AQE did not 
cause mortality. Low doses, however, led to 
weight gain. Although AQE may possess 
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beneficial effect against anemia and favor blood 
coagulation (platelets elevation); unfortunately, it 
seems that it may contain principles that exert 
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